Summary. The purpose of this study was to investigate whether the administration of acetoacetic and hydrochloric acids in a group of control and Type 1 (insulin-dependent) diabetic patients influenced renal haemodynamics. Renal plasma flow increased from 657 _+ 88 to 762___ 81 ml-min -1. 1.73 m -2 in diabetic patients (p < 0.01) and from 590__ 71 to 691 ___ 135 in control subjects (t7 < 0.01). Glomerular filtration rate increased from 135 _+ 9 to 180_ 8 ml-min -1.1.73 m -2 in diabetic patients (/7<0.001) and from 117_+8 to 145_+7 in control subjects (p < 0.01). Similar effects on renal haemodynamics, even if less pronounced, were observed with low dose acetoacetic but not with hydrochloric acid infusion. Total protein, fl2-microglobulin but not albumin excretion rates were increased by acetoacetic acid. We conclude that an acute increase in blood concentration of ketone bodies within the range found in diabetic patients with poor metabolic control (1) increases renal plasma flow and glomerular filtration rate both in control subjects and diabetic patients and (2) causes a tubular proteinuria.
Type 1 (insulin-dependent) diabetic patients show an increase in glomerular filtration rate (GFR), in comparison with normal subjects, when insulin treatment is inadequate to achieve satisfactory metabolic control [1] [2] [3] [4] [5] . The elevated GFR found in diabetic patients in poor metabolic control can be rapidly reversed by intensive insulin treatment, whilst kidney size remains enlarged [6] . This discordance between structure and function could support the hypothesis that functional haemodynamic rather than morphological changes play a major role in the generation of diabetic nephropathy [7] . It has been postulated that high circulating concentrations of glucose [8] , glucagon [9] and growth hormone [10] are responsible for the increase in GFR of poorly controlled diabetic patients. On the other hand, poorly controlled diabetes is characterized by abnormal blood concentrations of several hormones and metabolites. Concerning this issue, very little information is available on the individual role played by ketone bodies in determining haemodynamic changes in the kidney irrespective of changes of glucose, even if a high level of ketone bodies is one of the main clinical features of diabetic patients in poor metabolic control. Moreover, Christiansen et al. [8] pointed out that the acute changes seen in GFR following increments in plasma concentrations of glucose, glucagon and growth hormone within levels relevant to the clinical metabolic derangement shown by diabetic patients were 5%, 6% and 7%, respectively, whereas GFR is increased by approximately 25% in diabetic patients in poor metabolic control. Thus, it can be postulated either that haemodynamic effects of these factors in the kidney are additive or that other hormonal and metabolic factors contribute to modulate GFR in vivo.
The current study was undertaken to investigate whether ketone bodies per se are capable of influencing renal function in normal subjects and Type 1 diabetic patients in strict metabolic control.
To avoid the interference of changes of other metabolic parameters, we used the insulin-glucose clamp technique [11] to keep constant circulating concentrations of glucose and insulin during acetoacetic acid administration.
Subjects and methods

Subjects
Fourteen Type 1 diabetic patients without proliferative retinopathy and clinical renal complications (7 male, 7 female), and 14 normal subjects (8 male, 6 female), were investigated after obtaining informed and written consent. Normal subjects were either medical staff of the department or subjects admitted in the ward who did not show any kidney, liver, heart and metabolic disease. The control sub- Background retinopathy a C-peptide plasma value following intravenous injection of Img of glucagon; b body surface area was estimated according to the formula of DuBois and DuBois (36) jects' body mass index was 23.00_+1.11 kg/m 2, body surface was 1.72+0.30m 2, and age was 28+4years. C-peptide levels were 3.6 + 0.4 ng/ml after intravenous injection of 1 mg of glucagon, and blood pressure values were 120 + 6 mmHg (systolic) and 80 + 4 (diastolic). Haemoglobin A~c levels were 4.8 + 1.9%, creatinine clearance 127 _+ 11 ml/min, and albuminuria 8 + 2 mg/24 h. The clinical characteristics of the diabetic patients are shown in Table 1 . None of the diabetic patients received any drug other than insulin. Their metabolic control was satisfactory as demonstrated by the haemoglobin At o levels, which were close to the upper limit of normal subjects. One week before the study, the patients were admitted to the ward to optimize insulin therapy by monitoring day by day glucose profiles.
The day before the study patients received only their usual subcutaneous short-acting insulin dose at 08.00 and 12.00 hours. They were then connected overnight to the Biostator (Miles, Ames, Cavenago, Italy) in order to clamp blood glucose at 4.7 mmol/l [11] . In all patients this value was achieved and maintained at least 10 h before the investigation. Overnight insulin infusion rate was on average 1.2 _+ 0.3 IU/h (Monocomponent crystalline porcine insulin NOVO, Actrapid MC, Novo Italiana, Rome). The studies were performed according to the principles of the declaration of Helsinki.
Procedures and experimental design
At 07.00 hours a wrist vein of normal subjects and diabetic patients was cannulated in retrograde manner and the hand placed in a warming box to arterialize hand venous blood [11] . Intermittent blood samples were drawn from this vein to measure hormone and metabolite blood levels.
Only diabetic patients received a constant intravenous insulin infusion (15 mU. kg -1. h -~) by an independent pump (Harvard Apparatus, Millis, Mass, USA). Both normal subjects and diabetic patients were connected to the Biostator in run mode 9 : 1 to perform a completely automated blood glucose clamp at 4.7 mmol/1 [12] . Glomerular filtration rate (GFR) was measured by means of a constant 0.7 ~tCi infusion of 51Cr-EDTA (Specific activity: 1-2 ~tCi/mg Cr, Amersham Ltd, Buckinghamshire, UK) preceded by a priming dose of 50 ~tCi tracer [4, 13] .
Renal plasma flow (RPF) was calculated by a constant infusion of 0.2 ~tCi 12SI-hippurate [14] preceded by a priming dose of 30 ~tCi tracer.
At 07.00 hours the subjects drank one liter of tap water. To further obtain constant diuresis, 0.2 1 of water was given every 30 min throughout the study. At 08.00 hours SlCr-EDTA and nSI-hippurate solutions were started.
To achieve a steady state condition with regard to urinary flow, SlCr-EDTA and ~2SI-hippurate blood concentrations, measurements were commenced in the supine position after a period of 120 min at 10.00 hours. The subjects stood only to void. The above described procedure was followed in the following three protocols: Study 1. Kidney function was investigated in seven Type 1 diabetic patients (patients 1 to 7 in Table 1 ) and in seven normal subjects receiving 2 h intravenous infusion of isotonic saline (25 lxmol.kg -1. min -1) (0.730 _+ 0.101 1-h-1; molar concentration of the infused solution 0.154mol/I), then 2h acetoacetic acid infusion (251xmoi. kg-a.min -a) (0.730+0.101 1-h-a; molar concentration of the infused solution 0.154mol/1) and then again 2h isotonic saline (25 panol, kg -1. min-a). Four clearance periods were carried out during each infusion.
Study 2.
Kidney function was studied in other seven diabetic patients (patients 8 to 14 in Table 1 ) and seven normal subjects with the same procedure described above, except that the rate of infusion either for saline or for acetoacetic acid was 15 lxmol-kg-l.min -1 (fluid infusion rate 0.438+0.071 1.h-l; molar concentration of the infused solution 0.154 mol/1).
Study 3.
Kidney function was studied in five normal subjects and five diabetic patients (Numbers 9, 11, 13, 14, 15 in Table 1 ) with the same procedure described above except that hydrochloric acid, instead of acetoacetic acid, was infused at a rate of 10 ~tmol.kg -1. miu -~ (fluid infusion rate 0.292+0.069 1.h-a; molar concentration infused solution 0.154 mol/1).
Sodium acetoacetate was prepared from ethyl acetoacetate (Riedel-De HaenAg, Seelze-Hannover, FRG). Hydrolysis was performed with a 2N NaOH solution and incubation for 60 rain at 45 ~ After neutralization with 1N HC1, the solution was washed six times with diethylether and bubbled with N2 in crushed ice [15, 16] .
Acetoacetic acid was produced by passing sodium acetoacetate solution through a 1.0 m glass column (4 cm I.D.) containing a cation exchange resin (AG 50W-X8 100-200 mesh hydrogen form BioRad, Richmond, Calif, USA) at 2 ~ temperature. The pH of the acetoacetic acid solution after passing through this column was 1.9, with a 1.4 mol/l concentration versus a theoretical 1.69 tool/1 concentration (recovery 78%). Further procedures have been previously described [15] . The solution of hydrochloric acid had a pH of 0.99. All the delivered solutions were nearly isotonic (0.154 tool/l). All the solutions of tracers, acetoacetic acid and hydrochloric acid were set up the day before each study and passed through a Millipore filter (0.22 ~tm Millipore Corp. Bedford, Mass, USA), kept frozen at -20 ~ during the night and kept cool with ice cold water flowing through a polyethylene coil around the infusate syringes during the experiments. All the infusates were administered through a polyethylene coil around the infusate syringes during the experiments. All the infusates were administered through a polyethylene catheter manually advanced to the superior vena cava (Drum Cartridge, Abbott Lab, Chicago, Ill, USA).
Albumin and f12 microglobulin were measured by radioimmunoassay techniques [17, 18] . The lowest detection limit for urine albumin assay was 1.5 Ixg/ml. Normal range for albuminuria was 0.7-13.8 ~tg/min. Total proteinuria was measured according to the technique of Bradford [19] . Normal range for proteinuria was 15-100 ~g/min.
Blood glucose was measured with an analyzer using the hexokinase method [20] . 3-hydroxybutyrate was measured using an automated fluorimetric technique as described by Lloyd et al. [211. Acetoacetate was measured according to the spectrophotometric technique of Price et al. [22] .
Free insulin was measured in plasma previously treated by polyethylene glycol both in normal subjects and diabetic patients by radioimmunoassay techniques [23] . Free insulin intra-assay and interassay coefficients of variation were 6% and 8% respectively. Glucagon and growth hormone plasma levels were measured by radioimmunoassay techniques [24, 25] . Intra-assay and interassay coefficients of variation were 7% and 9%, respectively, for glucagon and 5% and 7%, respectively, for growth hormone. C-peptide was measured by radioimmunoassay technique [26] using the Biodata method (Biodata, Milan, Italy). The lowest limit of detection was 0.3 ng/ ml. The intra-assay and interassay coefficients of variation were 4% and 6% respectively. Haemoglobin A1~ levels were determined according to the technique of Schwartz et al. [27] . The range of normal values was 4.0-6.3%. The SlCr-EDTA and 12SI-hippurate radioactivity of the infusate tracer solution, plasma and urine samples were measured in a y-counter (Hewlett-Packard, Padua, Italy). Plasma renin activity was measured by radioimmunoassay technique [28] . Heart rate and auscultatory blood pressure (Korotkoff IV method) were measured in the middle of each 60-min period during the study. Plasma concentrations of sodium, potassium, bicarbonate, total protein and haematocrit were measured by standard methods.
Statistical analysis
The results are expressed as means +_ SD. Two way analysis of variance was used to assess statistical differences between normal subjects and diabetic patients and between baseline saline and acetoacetic acid infusion values. Newmann Keuls test was then used to assess statistical differences between individual points [29] . A p value of 0.05 was considered statistically significant. (Figs. 1 and 2 ). Total plasma ketone body concentration rose to a maximum level of 1.853+ 0.180 mmol/1 (p<0.01 vs basal level) in control subjects and to 2.127 +_ 0.160 mmol/1 (p < 0.01 vs basal level) in diabetic patients during acetoacetic acid infusion (Fig.l) . Plasma glucagon concentrations during acetoacetic acid administration (52 + 8 and 74+ 11 pg/ml in normal subjects and diabetic patients respectively) were comparable to the hormonal patterns observed during saline infusion (50+14 and 77+16 pg/ml in normal subjects and diabetic patients), Basal growth hormone levels of diabetic patients (5 + 3 ng/ml) and of normal subjects (6+2 ng/ml) were unchanged during acetoacetic acid infusion (6 +4 ng/ml in diabetic patients and 7 + 2 in normal men). Plasma renin activity was comparable in normal subjects and diabetic patients during saline infusion (1.03+0.40ng-ml-t.h -1 in control subjects vs 0.92 + 0.37 in diabetic patients) and decreased significantly at the end of acetoacetic acid infusion in both groups (0.64 + 0.30 in control subjects vs 0.60 + 0.22 in diabetic patients (p < 0.01)). GFR increased from a basal value of 117+8 to 145+7 ml. min -1.1.73 m -2 (p <0.01) during acetoacetic acid infusion (24% increase) in control subjects and from 135 + 9 to 180 + 8 (p < 0.001) (33% increase) in diabetic patients (Fig. 2) . RPF was 590 + 71 and 657 + 88 mlmin -1.1.73 m -2 in normal subjects and diabetic patients, respectively, during saline infusion, and was significantly increased to 691+I35 (p<0.05) and 762+ 81 (p < 0.005) by acetoacetic acid infusion in normal subjects and diabetic patients respectively (Fig. 2) .
Results
Renal haemodynamics during euglycaemic insulin-glucose clamp Study I
When acetoacetic acid infusion was stopped and again replaced by saline infusion (25 ~tmol-kg -t- Figure 1 min-t), glucose requirement, total ketone body concentration, GFR and RPF decreased to the values observed during basal saline infusion. Urinary flow as well as blood pressure were not modified by ketone administration. The filtration fraction was 0.20___0.04 and 0.21 __+0.06, respectively, in normal subjects and diabetic patients during saline infusion. Acetoacetic acid infusion increased the filtration fraction significantly (p < 0.05) in comparison with baseline saline infusion in diabetic patients (0.24_+0.04, p <0.05) but not in control subjects (0.21 _+ 0.06). When acetoacetic acid was replaced again by saline infusion, both GFR and RPF decreased in control subjects and diabetic patients to the values found during baseline saline infusion (Fig. 2) .
Ketone body tubular reabsorption rate was 11.7_+ 2.3 and 22.8_+4.3 ~tmol.min-l-l.73m -2 in control subjects and in diabetic patients, respectively, during saline infusion and 214.9_+19.3 and 306.3 _+33.7, respectively, during acetoacetic acid infusion.
Plasma sodium concentrations (142.7_+ 3.5 mmol/1 in control subjects vs 143.4_+ 3.3 in diabetic patients) were comparable between both study groups and did not differ both during acetoacetic acid infusion (142.8 _+ 3.2 in control subjects vs 143.3 _+ 2.3 in diabetic patients) and during saline infusion of the recovery phase (141.9+3.4 in control subjects vs 142.9 +2.7 in diabetic patients).
Basal pH and bicarbonate plasma concentrations were 7.382+0.021 and 26.1+1.4mmol/1 in normal subjects and 7.392+0.032 and 25.6+2.2 mmol/1 in diabetic patients, respectively, during isotonic saline infusion. During acetoacetic acid infusion, pH and bicarbonate plasma concentrations did not change significantly in both groups (7.384__+0.04 and 25.0_+ 1.7mmol/l in control subjects and 7.389_+0.031 and 23.0 + 1.3 mmol/1 in diabetic patients). During the recovery phase saline infusion the pH and bicarbonate plasma concentrations were 7.389-+0.039 and 24.9_+ 1.9 mmol/1 in control subjects and 7.393-+ 0.042 and 24.2 _+ 1.7 mmol/1 in diabetic patients.
The haematocrit decreased equally in both groups. During the first saline infusion the haematocrit was 45 + 20/0 ', during acetoacetic acid infusion 43 -+ 1%, and during the second saline infusion 43_+2% in control subjects; in diabetic patients during the first saline infusion the haematocrit was 44 _+ 3%, during acetoacetic acid infusion 42 + 2%, and during second saline infusion 41 _+3%. During the first saline, acetoacetic acid and second saline infusion plasma protein concentrations were 7.0 ___ 0.1 g/dl, 6.8 _+ 0.3 and 6.8 -+ 0.4 in control subjects and 6.9 -+ 0.7, 6.7 _+ 0.8 and 6.6 _+ 0.9 in diabetic patients. Arterial blood pressure did not change significantly during the study (123/80_+ 6/6 mmHg during isotonic saline infusion and 121/81_+7/8 mmHg during acetoacetic acid infusion in diabetic patients; 120/80_+ 5/4 mmHg in normal subjects before and 121/78_+ 7/7 mmHg during acetoacetic acid infusion). No variation was observed in heart rate in the two groups during the experiment.
Study 2 (Fig. 3) . 15 ~tmol-kg -t. min -1 acetoacetic acid infusion resulted in an increase in circulating levels of total ketone bodies which increased to a peak concentration of 0.761 _+ 0.182 mmol/1 and 0.993 _+ 0.092 mmol/1 in normal subjects and diabetic patients respectively. GFR increased from a basal value of 119 _+ 6 to 130 +_ 6 ml. min -t. 1.73 m -2 (p < 0.01) during acetoacetic acid infusion (9% increase) in control subjects and from 126 _+ 11 to 146 _+ 10 (p < 0.01) (16% increase) in diabetic patients. RPF was 531_+67 and 579_+ 62 ml. min -1-1.73 m -2 in control subjects and diabetic patients, respectively, during saline infusion and in control subjects (p < 0.05) 599 _+ 52 ml. min-1. No change in pH, plasma bicarbonate, arterial blood pressure or heart rate was seen during the study. The decrease in haematocrit and in plasma protein concentration was almost identical to that observed in Study 1.
Study 3 (Fig. 4) . 10 l~mol 9 kg-x. min-a hydrochloric acid infusion did not cause any significant change in circulating levels of ketone bodies. Baseline GFR values were 121_+8 and 128_+12 ml-min-l.l.73 m -2 in normal subjects and diabetic patients, respectively, and were not significantly changed by hydrochloric acid infusion (119_+9 and 127_+13). RPF was 527_+77 and 564_+72ml.min-t-1.73 m -2 in normal subjects and diabetic patients, respectively, during baseline saline infusion and did not change during hydrochloric acid administration (531 _+ 84 and 651 _+ 93 respectively). Basal pH and plasma bicarbonate concentrations were 7.385 _+ 0.022 and 25.7 _+ 1.5 mmol/1 in normal subjects and 7.391_+0.031 and 25.2_+1.6 mmol/1 in diabetic patients during baseline saline infusion. Hydrochloric acid infusion resulted in a significant decrease in pH values both in normal subjects and diabetic patients (7.361 __+ 0.019, p < 0.01 and 7.372 _+ 0.021, p < 0.01 respectively). Plasma bicarbonate concentration also decreased significantly to a value of 24.3 + 1.3 mmol/1 in normal subjects (p < 0.05) and a value of 23.9 + 1.7 in diabetic patients (p<0.01). No changes in arterial blood pressure, heart rate and plasma concentrations of glucagon and growth hormone were observed during hydrochloric acid infusion in comparison with baseline saline infusion. The decrease in haematocrit and in plasma protein concentration was similar to that shown during Study 2. Figure 5 shows total protein, albumin and fl2-microglobulin urinary excretion rate determined in Study 1 of normal subjects and diabetic patients during isotonic saline, acetoacetic acid and isotonic saline infusions. Acetoacetic acid administration significantly (p < 0.01) increased total protein and fl2-microglobulin excretion rate without affecting albumin excretion rate both in normal subjects and diabetic patients. The ratio between fl2-microglobulin excretion rate and GFR was also significantly elevated (p < 0.05) by acetoacetic administration in both groups of subjects. The patterns of fl2-microglobulin excretion rate during the final isotonic saline infusion decreased to the levels found during baseline saline administration.
Urinary protein excretion rates
Discussion
An elevated GFR in patients with early short-term Type I diabetes mellitus has been found by several authors [1] [2] [3] [4] [5] . There is evidence suggesting that an increased blood flow resulting in an increased GFR can contribute to the development of diabetic glomerulosclerosis [7, 30] .
The purpose of the present study was to investigate whether an acute increase in blood levels of ketone bodies at stable plasma levels of glucose and insulin was capable of increasing GFR both in normal subjects and diabetic patients. Two rates of acetoacetic acid infusion were chosen in order to achieve circulating concentrations of ketone bodies in the range usually observed in poorly controlled diabetic patients during subcutaneous insulin therapy or in a more advanced ketotic state even without acidosis or dehydration [31] .
In both groups of subjects blood glucose was clamped at 4.7 mmol/1 throughout the entire experiment. Glucagon and growth hormone concentrations were not modified by acetoacetic acid administration. GFR was significantly enhanced by acetoacefic acid administration both at low and high infusion rates. This effect was dose-dependent, since the increase in GFR was twice as great at high than at low acetoacetic acid infusion. Diabetic patients showed a greater increase in GFR following ketone body challenge than normal subjects. The increase in GFR was associated in both groups with an enhancement in RPF.
The saline period and the acetoacetic acid infusion period did not differ with regard to volume and tonicity of administered infusates.
In order to rule out that the haemodynamic effects induced by acetoacetic acid were due to the amount of acid given (i. e. the protons associated to the acetoacetate), we infused hydrochloric acid both in normal subjects and diabetic patients. Hydrochloric acid administration had no effect on GFR and RPF, even if there was a significant decrease in blood pH.
As for the amount of sodium administered, we have previously shown an increase in GFR values similar to that found in the current study, during the administration of the sodium salt of ketone bodies [32] , suggesting that the haemodynamic changes are due to the acid form of the organic acid rather than to changes in the amount of administered sodium. Moreover, the increase in GFR and RPF cannot be due to sodium and water loading throughout the study, since GFR and RPF returned to basal levels as soon as acetoacetic acid infusion was stopped and saline was again infused. These results are in agreement with previous reports which demonstrated that GFR and RPF remained unchanged during sustained water diuresis [33, 34] and during infusion of more than 50 ml/min of isotonic saline [35] . With regard to plasma renin activity (PRA), we did not find any increase in circulating pattern of PRA during acetoacetic acid administration, suggesting that renin-angiotensin II system is not activated by ketone body administration. Thus, a specific effect of ketone bodies has to be postulated to account for the findings of the present study. It has been reported that RPF is elevated in short-term diabetic patients and a positive correlation between RPF and GFR has been demonstrated [37] . The current findings demonstrate that increase in blood levels of ketone bodies plays an independent role in the enhancement of RPF and GFR in Type 1 diabetes and suggest that the increase in GFR is at least partially due to an increase in RPF. Concerning this topic, blood flow is almost twice that of normal control subjects in the forearm of newly diagnosed poorly controlled diabetic patients [38] . Increased blood flow has also been reported in the brain, muscle, fat, skin and kidney in hyperglycaemic ketotic diabetic patients [38] , and it can be completely normalized by strict metabolic correction [38] . We postulate that the increase in ketone body blood concentrations is the cause of a reversible vasodilatation resulting in an increased RPF at kidney site. With regard to the ketone body infusion at high rate, it has to be pointed out that the increase in RPF was similar in normal subjects and diabetic patients, whereas the elevation in GRF was higher in diabetic patients. This phenomenon was not evident at low ketone body infusion rates. Thus, filtration fraction was significantly increased by 25 ~tmol.kg -1 .min -t acetoacetic acid inft/s~ion in diabetic patients but not in normal subjects. With regard to this last finding it has been reported that Type 1 diabetic patients in poor metabolic control with elevated ketone body levels are characterized by a high filtration fraction which decreases towards normal value after one week of good metabolic control [37] .
Ditzel et al. [39] found that an increased plasma (and ultrafiltrate) glucose concentration leads to a stimulation of sodium-coupled glucose reabsorption and thereby of solute-linked water reabsorption.
The excess sodium-solute-linked reabsorption was interpreted to be basic for the mechanism leading to the elevated GFR in the diabetic patients [39] . The role of ketone bodies from this point of view should be even more crucial, since reabsorptive rates of acetoacetate, 3-hydroxybutyrate and acetone increase linearly with their filtered loads, no maximal renal tubular transport rates were demonstrated for any ketone body [40] and renal reabsorption of ketone bodies is usually thought to be more efficient than that of glucose [40] . This unlimited capacity of the renal tubulus to transport ketone bodies coupled with sodium and ammonium could lead to a linearly related solute-linked water reabsorption.
In the current study we showed an acute effect of the marked increase of circulating ketone bodies on kidney haemodynamics. Further studies will be needed to investigate whether a similar effect is still present after a chronic increase in ketone bodies in blood. With regard to protein excretion rate following ketone body administration, we found that acetoacetic acid infusion significantly increased total protein and fl2-microglobulin but not albumin excretion rate. This effect was clearly observed both in normal subjects and in diabetic patients. These findings suggest that an acute shortterm increase in blood levels of ketone bodies enhances tubular but not glomerular proteinuria. Moreover, this finding is confirmed by the ratio between fl2-microglobulin excretion rate and GFR. Our results are in keeping with the recent report of Nagulesparan et al. [41] , who observed a marked increase in total protein but not in albumin excretion rate in obese Type 2 (non-insulin-dependent) diabetic patients with high ketone body blood levels during prolonged fasting.
In conclusion, our results indicate that an acute short term increase in blood concentration of ketone bodies within a range often observed in diabetic patients in poor metabolic control although not in ketoacidosis (1) increases renal plasma flow and glomerular filtration rate in normal Type i diabetic patients; mad (2) causes a tubular proteinuria, as suggested by higher excretion rate of total urinary protein and fl2-microglobulin without changes in albumin excretion rate.
These findings seem to be due to the effects of the organic acid itself rather than to the associated protons R.Trevisan et al.: Kidney function and blood ketone bodies administered, since hydrochloric acid administration did not change renal haemodynamics.
